Healthcare -
Biotechnology - NASDAQ - US
$ 0.26
3.09 %
$ 16.8 M
Market Cap
-0.42
P/E
GLYC - REVENUE
Revenue GLYC - GlycoMimetics, Inc.
10 K
LAST VALUE
-90.72%
2 YEAR CAGR
0.00%
5 YEAR CAGR
-45.06%
10 YEAR CAGR